| Attribute |
Value |
| 52 Week Change |
0.10812652 |
| Address1 |
358 South Main Street |
| All Time High |
293.72 |
| All Time Low |
2.416237 |
| Ask |
0.0 |
| Ask Size |
40 |
| Audit Risk |
3 |
| Average Analyst Rating |
1.6 - Buy |
| Average Daily Volume10 Day |
651,330 |
| Average Daily Volume3 Month |
654,377 |
| Average Volume |
654,377 |
| Average Volume10Days |
651,330 |
| Beta |
0.861 |
| Bid |
0.0 |
| Bid Size |
440 |
| Board Risk |
7 |
| Book Value |
106.058 |
| City |
Burlington |
| Compensation As Of Epoch Date |
1,767,139,200 |
| Compensation Risk |
3 |
| Country |
United States |
| Crypto Tradeable |
0 |
| Currency |
USD |
| Current Price |
276.68 |
| Current Ratio |
1.726 |
| Custom Price Alert Confidence |
HIGH |
| Date Short Interest |
1,782,777,600 |
| Day High |
279.77 |
| Day Low |
275.94 |
| Debt To Equity |
83.407 |
| Display Name |
Labcorp |
| Dividend Date |
1,789,084,800 |
| Dividend Rate |
2.88 |
| Dividend Yield |
1.04 |
| Earnings Call Timestamp End |
1,785,441,600 |
| Earnings Call Timestamp Start |
1,785,441,600 |
| Earnings Growth |
0.329 |
| Earnings Quarterly Growth |
0.305 |
| Earnings Timestamp |
1,785,414,600 |
| Earnings Timestamp End |
1,785,414,600 |
| Earnings Timestamp Start |
1,785,414,600 |
| Ebitda |
2,252,999,936 |
| Ebitda Margins |
0.15929 |
| Enterprise To Ebitda |
12.88 |
| Enterprise To Revenue |
2.052 |
| Enterprise Value |
29,017,960,448 |
| Eps Current Year |
18.00463 |
| Eps Forward |
19.44171 |
| Eps Trailing Twelve Months |
11.29 |
| Esg Populated |
0 |
| Ex Dividend Date |
1,787,875,200 |
| Exchange |
NYQ |
| Exchange Data Delayed By |
0 |
| Exchange Timezone Name |
America/New_York |
| Exchange Timezone Short Name |
EDT |
| Fifty Day Average |
263.343 |
| Fifty Day Average Change |
13.337006 |
| Fifty Day Average Change Percent |
0.050645 |
| Fifty Two Week Change Percent |
10.812653 |
| Fifty Two Week High |
293.72 |
| Fifty Two Week High Change |
-17.040009 |
| Fifty Two Week High Change Percent |
-0.058014464 |
| Fifty Two Week Low |
241.81 |
| Fifty Two Week Low Change |
34.869995 |
| Fifty Two Week Low Change Percent |
0.14420411 |
| Fifty Two Week Range |
241.81 - 293.72 |
| Financial Currency |
USD |
| First Trade Date Milliseconds |
638,721,000,000 |
| Float Shares |
81,602,300 |
| Forward Eps |
19.44171 |
| Forward P E |
14.231258 |
| Free Cashflow |
1,142,537,472 |
| Full Exchange Name |
NYSE |
| Full Time Employees |
71,000 |
| Gmt Off Set Milliseconds |
-14,400,000 |
| Governance Epoch Date |
1,782,864,000 |
| Gross Margins |
0.28834 |
| Gross Profits |
4,078,299,904 |
| Has Pre Post Market Data |
1 |
| Held Percent Insiders |
0.0035499998 |
| Held Percent Institutions |
1.0103099 |
| Implied Shares Outstanding |
82,000,000 |
| Industry |
Diagnostics & Research |
| Industry Disp |
Diagnostics & Research |
| Industry Key |
diagnostics-research |
| Is Earnings Date Estimate |
0 |
| Language |
en-US |
| Last Dividend Date |
1,780,012,800 |
| Last Dividend Value |
0.72 |
| Last Fiscal Year End |
1,767,139,200 |
| Last Split Date |
1,688,342,400 |
| Last Split Factor |
1,164:1000 |
| Long Business Summary |
Labcorp Holdings Inc. provides laboratory services. It operates in Diagnostics Laboratories and Biopharma Laboratory Services segments. The company offers various tests, such as blood chemistry analyses, urinalyses, blood cell counts, thyroid tests, PAP tests, hemoglobin A1C, PSA, tests for sexually transmitted diseases, vitamin D testing, microbiology cultures and procedures, and alcohol and other substance abuse tests. It also provides specialty testing services comprising gene-based and esoteric testing; advanced tests target specific diseases; services related to anatomic pathology/oncology, cardiovascular disease, coagulation, diagnostic genetics, endocrinology, infectious disease, women's health, pharmacogenetics, parentage and donor testing, occupational testing service, medical drug monitoring services, chronic disease programs, and kidney stone prevention tests; and health and wellness services to employers and managed care organizations. In addition, it offers digital pathology solutions, a pathology platforms that support the digitization, centralized review, and sharing of pathology slides; provider and payer digital platforms, an online applications for providers, MCOs, and ACOs; online and mobile applications that enable patients to check offerings, schedule PSC visits, check-in upon PSC arrival, complete documentation, access tests and test results, and manage their accounts; and Generative AI enabled Test Selection, a generative AI enabled tool. It serves clients, third party, medicare/medicaid, patients, pharmaceutical, biotechnology, medical device, diagnostic companies, and CROs. It has a strategic collaboration with the Children's Hospital of Philadelphia to accelerate the discovery, development, and availability of pediatric diagnostics; and Alliance for Clinical Trials in Oncology to advance national clinical trial for patients diagnosed with colorectal cancer. The company was founded in 1995 and is headquartered in Burlington, North Carolina. |
| Long Name |
Labcorp Holdings Inc. |
| Market |
us_market |
| Market Cap |
22,687,760,384 |
| Market State |
PREPRE |
| Max Age |
86,400 |
| Message Board Id |
finmb_30643 |
| Most Recent Quarter |
1,774,915,200 |
| Name Change Date |
2,026-07-13 |
| Net Income To Common |
941,500,032 |
| Next Fiscal Year End |
1,798,675,200 |
| Non Diluted Market Cap |
22,698,420,000 |
| Number Of Analyst Opinions |
17 |
| Open |
277.2 |
| Operating Cashflow |
1,813,500,032 |
| Operating Margins |
0.10945 |
| Overall Risk |
1 |
| Payout Ratio |
0.2551 |
| Peg Ratio |
1.17 |
| Phone |
336 229 1127 |
| Post Market Change |
-4.2299805 |
| Post Market Change Percent |
-1.5288349 |
| Post Market Price |
272.45 |
| Post Market Time |
1,783,985,650 |
| Prev Name |
Laboratory Corporation of America Holdings |
| Previous Close |
276.81 |
| Price Eps Current Year |
15.367159 |
| Price Hint |
2 |
| Price To Book |
2.6087613 |
| Price To Sales Trailing12 Months |
1.6040328 |
| Profit Margins |
0.06656 |
| Quick Ratio |
1.299 |
| Quote Source Name |
Nasdaq Real Time Price |
| Quote Type |
EQUITY |
| Recommendation Key |
buy |
| Recommendation Mean |
1.63158 |
| Region |
US |
| Regular Market Change |
-0.130005 |
| Regular Market Change Percent |
-0.0469654 |
| Regular Market Day High |
279.77 |
| Regular Market Day Low |
275.94 |
| Regular Market Day Range |
275.94 - 279.77 |
| Regular Market Open |
277.2 |
| Regular Market Previous Close |
276.81 |
| Regular Market Price |
276.68 |
| Regular Market Time |
1,783,972,802 |
| Regular Market Volume |
292,658 |
| Return On Assets |
0.05314 |
| Return On Equity |
0.11047 |
| Revenue Growth |
0.058 |
| Revenue Per Share |
170.669 |
| Sand P52 Week Change |
0.20847368 |
| Sector |
Healthcare |
| Sector Disp |
Healthcare |
| Sector Key |
healthcare |
| Share Holder Rights Risk |
1 |
| Shares Outstanding |
82,000,000 |
| Shares Percent Shares Out |
0.0345 |
| Shares Short |
2,830,398 |
| Shares Short Previous Month Date |
1,780,012,800 |
| Shares Short Prior Month |
3,426,602 |
| Short Name |
Labcorp Holdings Inc. |
| Short Percent Of Float |
0.0346 |
| Short Ratio |
4.43 |
| Source Interval |
15 |
| State |
NC |
| Symbol |
LH |
| Target High Price |
340.0 |
| Target Low Price |
270.0 |
| Target Mean Price |
312.17648 |
| Target Median Price |
320.0 |
| Total Cash |
981,100,032 |
| Total Cash Per Share |
11.965 |
| Total Debt |
7,294,400,000 |
| Total Revenue |
14,144,199,680 |
| Tradeable |
0 |
| Trailing Annual Dividend Rate |
2.88 |
| Trailing Annual Dividend Yield |
0.010404249 |
| Trailing Eps |
11.29 |
| Trailing P E |
24.506643 |
| Trailing Peg Ratio |
1.1706 |
| Triggerable |
1 |
| Two Hundred Day Average |
267.35474 |
| Two Hundred Day Average Change |
9.325256 |
| Two Hundred Day Average Change Percent |
0.034879714 |
| Type Disp |
Equity |
| Volume |
292,658 |
| Website |
https://www.labcorp.com |
| Zip |
27,215 |